Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M. TSYGANOVA"'
Autor:
D. S. Leontyev, F. A. Urusov, D. V. Glazkova, B. V. Belugin, O. V. Orlova, R. R. Mintaev, G. M. Tsyganova, E. V. Bogoslovskaya, G. A. Shipulin
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 312-321 (2024)
INTRODUCTION. Despite existing treatment methods, complete eradication of human immunodeficiency virus (HIV) infection remains an unattainable goal due to the high variability of HIV type 1 (HIV-1). HIV infection necessitates life-long administration
Externí odkaz:
https://doaj.org/article/b076f82274424b8192a6f8cb79b849bc
Publikováno v:
Psychology in Russia: State of Art, Vol 17, Iss 2, Pp 3-22 (2024)
Background. Children’s and adolescents’ development of autonomy depends on the relationship with their parents and the parents’ child-rearing practices. These might be aimed towards supporting or restricting autonomy, as well as its different a
Externí odkaz:
https://doaj.org/article/ff17f3f4537442579967a7a6484f1c8f
Autor:
German A. Shipulin, Dina V. Glazkova, Felix A. Urusov, Boris V. Belugin, Valeriya Dontsova, Alexandra V. Panova, Alyona A. Borisova, Galina M. Tsyganova, Elena V. Bogoslovskaya
Publikováno v:
Viruses, Vol 16, Iss 8, p 1296 (2024)
Anti-human immunodeficiency virus (HIV) broadly neutralizing antibodies (bNAbs) offer a promising approach for the treatment of HIV-1. The current paradigm for antibody therapy involves passive antibody transfer, requiring regular delivery of bNAbs i
Externí odkaz:
https://doaj.org/article/f25d97e05f7a448aa14ecf9167c5d6ca
Publikováno v:
Microorganisms, Vol 11, Iss 12, p 2838 (2023)
The development of effective diagnostic kits for HIV-1 remains a pressing concern. We designed diagnostic oligonucleotides for HIV-1 real-time PCR to target the most conserved region of the HIV-1 genome and assessed the mutation frequency at annealin
Externí odkaz:
https://doaj.org/article/83dc993706b84239b5490647af0a9082
Autor:
Ya. M. Tsyganova
Publikováno v:
Вестник Самарского университета: История, педагогика, филология, Vol 26, Iss 4, Pp 22-29 (2020)
The article examines the problem of the image of Samara and the Samara region in the second half of the XIX early XX century, the face of Samara of that era, the brands of the city and the province. The author shows aspects of the sides of the image
Externí odkaz:
https://doaj.org/article/b5b7307df0f04e968b72fc5bcd5624c8
Autor:
F. A. Urusov, D. V. Glazkova, G. M. Tsyganova, D. V. Pozdyshev, E. V. Bogoslovskaya, G. A. Shipulin
Publikováno v:
Molecular Biology. 56:107-114
Autor:
F A, Urusov, D V, Glazkova, G M, Tsyganova, D V, Pozdyshev, E V, Bogoslovskaya, G A, Shipulin
Publikováno v:
Molekuliarnaia biologiia. 56(1)
The chimeric protein TRIM5α-HRH is a promising antiviral factor for HIV-1 gene therapy. This protein is able to protect cells from HIV-1 by blocking the virus in the cytoplasm. We are developing protocol of HIV-1 gene therapy, which involves the del
Autor:
Y. A. Zhogina, German A. Shipulin, E. V. Bogoslovskaya, G. M. Tsyganova, F. A. Urusov, D. V. Glazkova, D.O. Omelchenko
Publikováno v:
Molecular Biology. 52:251-261
Gene therapy is considered a promising approach to treating infections caused by human immunodeficiency virus (HIV). One strategy is to introduce antiviral genes into cells in order to impart resistance to HIV. In this work, the antiviral activity of
Autor:
E. V. Bogoslovskaya, G. M. Tsyganova, I.V. Antoshkina, R.R. Mintaev, German A. Shipulin, A.S. Tikhonov, O.V. Orlova, D. V. Glazkova
Publikováno v:
Journal of Virological Methods
Obtaining a pure recombinant Modified Vaccinia Ankara (MVA) virus is a multistage, time-consuming procedure. We describe a novel single-tube real-time PCR which enables determination of the amount of wild type and recombinant viruses and their ratio
Autor:
D.O. Omelchenko, V. V. Pokrovsky, Felix Urusov, German A. Shipulin, G. M. Tsyganova, D. V. Glazkova, Katerina Kersting, Elena Bogoslovskaya
Publikováno v:
Cells
Cells, Vol 7, Iss 2, p 10 (2018)
Cells; Volume 7; Issue 2; Pages: 10
Cells, Vol 7, Iss 2, p 10 (2018)
Cells; Volume 7; Issue 2; Pages: 10
C-C chemokine receptor type 5 (CCR5) is utilized by human immunodeficiency virus (HIV) as a co-receptor for cell entry. Suppression of the CCR5 gene by artificial microRNAs (amiRNAs) could confer cell resistance. In previous work, we created a lentiv